Sonoma Pharmaceuticals (SNOA) Long-Term Deferred Tax (2022 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Long-Term Deferred Tax of $884000.0 for Q1 2026, up 50.08% year-over-year from $589000.0 in Q1 2025, and up 93.01% quarter-over-quarter from $458000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Long-Term Deferred Tax (2022 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Long-Term Deferred Tax history runs 5 years deep, the most recent figure standing at $884000.0 for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 50.08% year-over-year to $884000.0; the TTM figure through Mar 2026 stood at $884000.0 (up 50.08% YoY), while the FY2026 annual figure was $884000.0, up 50.08% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $884000.0, up from $458000.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $1.1 million in Q1 2024, with the low at $458000.0 in Q4 2025.
- The 5-year median for Long-Term Deferred Tax is $859000.0 (2022), against an average of $820941.2.
- The sharpest annual moves came in 2025 and 2026: Long-Term Deferred Tax tumbled 48.56% in 2025, then soared 50.08% in 2026.
- Sonoma Pharmaceuticals' Long-Term Deferred Tax stood at $1.1 million in 2022, then slipped by 15.34% to $922000.0 in 2023, then declined by 17.57% to $760000.0 in 2024, then sank by 39.74% to $458000.0 in 2025, then jumped by 93.01% to $884000.0 in 2026.
- Business Quant data shows SNOA's Long-Term Deferred Tax at $884000.0 in Q1 2026, $458000.0 in Q4 2025, and $508000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 905,000.00 |
| Mar 31, 2026 | 884,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Sep 30, 2025 | 508,000.00 |
| Jun 30, 2025 | 546,000.00 |
| Mar 31, 2025 | 589,000.00 |
| Dec 31, 2024 | 760,000.00 |
| Sep 30, 2024 | 792,000.00 |
| Jun 30, 2024 | 921,000.00 |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 922,000.00 |
| Sep 30, 2023 | 840,000.00 |
| Jun 30, 2023 | 908,000.00 |
| Mar 31, 2023 | 949,000.00 |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 957,000.00 |
| Jun 30, 2022 | 859,000.00 |
| Mar 31, 2022 | 829,000.00 |